Compare YUMC & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YUMC | BAX |
|---|---|---|
| Founded | 1987 | 1931 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.8B | 13.9B |
| IPO Year | 2016 | 1994 |
| Metric | YUMC | BAX |
|---|---|---|
| Price | $43.74 | $25.55 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $21.00 |
| AVG Volume (30 Days) | 1.3M | ★ 5.3M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.38% | 0.24% |
| EPS Growth | ★ 7.73 | N/A |
| EPS | ★ 1.57 | 0.21 |
| Revenue | ★ $11,797,000,000.00 | $11,244,000,000.00 |
| Revenue This Year | $9.42 | $1.96 |
| Revenue Next Year | $5.86 | $2.22 |
| P/E Ratio | ★ $27.89 | $121.12 |
| Revenue Growth | 4.37 | ★ 5.72 |
| 52 Week Low | $40.15 | $15.73 |
| 52 Week High | $58.39 | $30.00 |
| Indicator | YUMC | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 35.97 | 47.24 |
| Support Level | $42.46 | $18.31 |
| Resistance Level | $44.80 | $30.00 |
| Average True Range (ATR) | 1.02 | 0.69 |
| MACD | -0.59 | -0.29 |
| Stochastic Oscillator | 8.47 | 16.46 |
Yum China is the largest restaurant operator in China, with over 18,000 locations and USD 12 billion in systemwide sales as of 2025. It generates revenue primarily from its own restaurants and franchise fees. While KFC and Pizza Hut are its flagship brands, Yum China's portfolio also includes Little Sheep, Taco Bell, Huang Ji Huang, and Lavazza.As a trademark licensee of Yum Brands, Yum China pays 3% of KFC and Pizza Hut's systemwide sales to its former parent, from which it spun off in 2016. However, even before the separation, Yum China was granted substantial autonomy, giving its Chinese leadership decision-making authority over menu, supply chain, and marketing—an unusual practice for Western chains at the time.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.